Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Anette-Gabriele Ziegler - (Author)
  • Stefanie Arnolds - (Author)
  • Annika Kolln - (Author)
  • Peter Achenbach - (Author)
  • Reinhard Berner - , Department of Paediatrics (Author)
  • Ezio Bonifacio - , Chair of Preclinical stem cell therapy and diabetes, Center for Regenerative Therapies Dresden (Author)
  • Kristina Casteels - (Author)
  • Helena Elding Larsson - (Author)
  • Melanie Gundert - (Author)
  • Joerg Hasford - (Author)
  • Olga Kordonouri - (Author)
  • Markus Lundgren - (Author)
  • Mariusz Oltarzewski - (Author)
  • Marcin L. Pekalski - (Author)
  • Markus Pfirrmann - (Author)
  • Matthew D. Snape - (Author)
  • Agnieszka Szypowska - (Author)
  • John A. Todd - (Author)

Details

Original languageEnglish
Article numbere052449
JournalBMJ open
Volume11
Issue number11
Publication statusPublished - Nov 2021
Peer-reviewedYes

External IDs

Scopus 85112435223
ORCID /0000-0002-8704-4713/work/141544303

Keywords

Research priority areas of TU Dresden

Sustainable Development Goals

Keywords

  • general diabetes, immunology, diabetes & endocrinology, paediatrics, epidemiology

Library keywords